Latest American Society of Clinical Oncology Stories
CAMBRIDGE, Mass., Sept. 7, 2011 /PRNewswire/ -- Sermo, Inc. (www.sermo.com), the largest online physician network in the United States, today announced the launch of Sermo Sponsorship, a portfolio of offerings that provides new opportunities for pharmaceutical, biotechnology and life sciences companies to engage physicians and educate them on new products and programs. Sermo Sponsorship is available on both web and mobile platforms, where physicians across 68 specialties discuss top issues...
WASHINGTON, July 22, 2011 /PRNewswire-USNewswire/ -- As budget negotiations and debt ceiling discussions escalate on Capitol Hill, an increasing number of leading cancer care organizations and patient advocacy groups are expressing deep concern over proposed Medicare cuts to cancer-fighting drugs. This week, nine additional groups signed onto a letter, originally sent to the White House and Congressional Leadership on July 14, in which leading patient advocacy groups, community cancer care...
Promising results of PI3K inhibitor study discussed at ASCO annual meeting SCOTTSDALE, Ariz., July 20, 2011 /PRNewswire-USNewswire/ -- A new drug targeting the PI3K gene in patients with advanced breast cancer shows promising results in an early phase I investigational study conducted at Virginia G. Piper Cancer at Scottsdale Healthcare, according to a presentation by oncologist Dr. Daniel D. Von Hoff at the 47th annual meeting of the American Society of Clinical Oncology (ASCO). The drug...
Promising results of PI3K inhibitor study discussed at ASCO annual meetingA new drug targeting the PI3K gene in patients with advanced breast cancer shows promising results in an early phase I investigational study conducted at Virginia G. Piper Cancer at Scottsdale Healthcare, according to a presentation by oncologist Dr. Daniel D. Von Hoff at the 47th annual meeting of the American Society of Clinical Oncology (ASCO).The drug under investigation, GDC-0941, manufactured by Genentech Inc.,...
WASHINGTON, July 14, 2011 /PRNewswire/ -- The Community Oncology Alliance (COA) announced today that it has joined with multiple cancer and patient organizations, including The American Society of Clinical Oncology (ASCO), the National Patient Advocacy Foundation (NPAF) and U.S. Oncology, to urge President Obama and Congress not to sacrifice cancer care while they seek solutions to the national debt ceiling issue. The organizations -- representing patients, distributers, and over 30,000...
MEMPHIS, Tenn., June 30, 2011 /PRNewswire-USNewswire/ -- Accelerated Community Oncology Research Network, Inc., (ACORN), reported positive results of a large double-blind, randomized Phase 2b trial in patients with breast cancer at the American Society of Clinical Oncology (ASCO) 47th annual meeting in Chicago, June 3-7. The study, managed by ACORN Research, evaluated a novel drug regimen for the treatment of locally advanced or metastatic breast cancer. The regimen, Nexavar®...
ATLANTA, June 21, 2011 /PRNewswire/ -- MDOUTLOOK®, the global oncology intelligence initiative powered by The Arcas Group, announced results from 4th Annual Quick Poll research launched immediately following this month's annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago. These Quick Polls expand on previous Quick Polls carried out after the past 3 ASCO annual meetings, as well as similar efforts after the American Society of Hematology (ASH) annual meetings...
-- Pharma/biotech companies join together to fund Accelerating Cancer Cures, a new model of collaboration in cancer research led by the Damon Runyon Cancer Research Foundation -- $25 Million Fund to Support 50 Clinical Investigators Over Next Five Years -- Newest Clinical Investigator Award Winners Announced Today NEW YORK, June 21, 2011 /PRNewswire-USNewswire/ -- The Damon Runyon Cancer Research Foundation today announced the formation of "Accelerating Cancer Cures," a historic...
WASHINGTON, June 18, 2011 /PRNewswire-USNewswire/ -- LUNGevity Foundation and GRACE announce a free webinar program to provide the highlights in lung cancer research from the American Society for Clinical Oncology (ASCO) Annual Meeting held June 3-6, 2011 in Chicago. ASCO, the largest cancer conference of the year, is where the majority of the landmark clinical research in cancer care are presented. On the webinar participants will learn the results of the key research and also have it...
THE WOODLANDS, Texas, June 15, 2011 /PRNewswire/ -- Two clinical trial studies authored by physicians affiliated with US Oncology Research and the United Network of US Oncology have been selected to be featured in the Best of ASCO to be held July 29-30 in Miami and August 5-6 in Seattle. The American Society of Clinical Oncology (ASCO) hosted its 47th Annual Meeting June 3-7 at McCormick Place in Chicago. The Best of ASCO Meetings highlight the most relevant studies from the ASCO Annual...
